Acne Vulgaris
DUSA Pharmaceuticals Reports First Quarter 2007 Corporate Highlights and Financial Results
Published in Medical Device Business Week, May 23rd, 2007
Total product revenues for the first quarter were $6.7 million versus $4.8 million in the comparable 2006 period, a 41% year over year increase. The revenue increases were mainly reflective of Levulan(R) Kerastick(R) unit volume sales growth; as well as a full quarter of non-PDT revenues associated with products acquired in the merger with Sirius Laboratories,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Angina
Cardiogenesis Announces Submission of PMA Supplement for Minimally Invasive Robotic Delivery System - Artificial Organs
HepaLife Expands Management Team on Heels of Favorable Outcomes of First-of-Its-Kind Bioartificial Liver Device - Back Pain
ACSS Spine Surgeons Hear Professor F.W. Smith, M.D. Report That the FONAR UPRIGHT MRI Successfully Diagnosed 54% of the Back Pain Patients That Could NOT Be Diagnosed by Recumbent MRI - Biomedical Engineering
Axela Biosensors to Develop Commercial Biomarker Assays with BioCheck's Antibody Reagents - Biomedical Engineering
California Healthcare Institute Applauds Introduction of R&D Tax Credit - Biomedical Engineering
Investigators at Novo Nordisk have published new data on biomedical engineering - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
